Graeser M, Gluz O, Zu Eulenburg C, Kuemmel S, et al. Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A pooled analysis of three WSG trials. Ann Oncol 2025 Aug 4:S0923-7534(25)00913-5. doi: 10.1016/j.annonc.2025.
PMID: 40769278